Xylem Inc (XYL)
Official siteINDUSTRIALS • SPECIALTY INDUSTRIAL MACHINERY • NYSE
Market Cap: $21.60B
Last updated: Nov 17, 2026 at 4:42 PM ET
Xylem Inc (XYL) Statistics
Xylem (XYL) has a market cap of $21.60B and an enterprise value of $23.79B. Its share count is down 4.41% from a year earlier. Its trailing P/E of 17.4x is below its 10-year median of 29.1x.
Total Valuation
Enterprise value is 10.13% above the market cap, as debt exceeds cash.
| Market Cap | $21.60B |
|---|---|
| Enterprise Value | $23.79B |
| Latest price (Nov 17, 2026) | $94.64 |
Key Dates
The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Aug 27, 2026.
| Next Earnings Date | Feb 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 27, 2026 |
| Last Ex-Dividend Date | Aug 27, 2026 |
| Last Payment Date | Sep 24, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.4x and 2.1x. Its year-end P/E ranged from 23.1x to 49.4x from 2016 to 2025.
| P/E Ratio | 17.4x |
|---|---|
| Forward P/E | 17.3x |
| P/S Ratio | 2.4x |
| Forward P/S | 2.4x |
| P/B Ratio | 2.1x |
| P/FCF Ratio | 23.9x |
| P/OCF Ratio | 17.0x |
| PEG Ratio | 1.9 |
Enterprise Valuation
Counting debt and cash, the company is valued at 12.5x EBITDA and 26.3x free cash flow.
| EV / Earnings | 22.2x |
|---|---|
| EV / Sales | 2.6x |
| EV / EBITDA | 12.5x |
| EV / EBIT | 17.2x |
| EV / FCF | 26.3x |
Price Statistics
The stock is down 33.02% over 52 weeks and trades 7.03% below its 50-day average.
| Beta (1Y) | 0.57 |
|---|---|
| 52-Week Change | -33.02% |
| 1-Month Change | -8.59% |
| 3-Month Change | -18.25% |
| 6-Month Change | -10.31% |
| 5-Year Change | -29.24% |
| 10-Year Change | +91.19% |
| Total Return (1Y) | -31.82% |
| Total Return (3Y CAGR) | -1.10% |
| Total Return (5Y CAGR) | -5.09% |
| Return vs SPY (1Y) | -43.35% |
| Max Drawdown (1Y) | -39.18% |
| Max Drawdown (3Y) | -41.73% |
| Sharpe Ratio (1Y) | -1.23 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $101.80 |
| 200-Day Average | $114.23 |
| 52-Week Range | $87.40 to $144.93 |
| RSI (14 Days) | 42.0 |
| Average Volume (20 Days) | 3.70M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.39x current liabilities, and total debt is 0.28x shareholder equity.
| Current Ratio | 1.39x |
|---|---|
| Quick Ratio | 1.02x |
| Debt / Equity | 0.28x |
| Debt / EBITDA | 1.49x |
| Debt / FCF | 3.14x |
| Interest Coverage | 36.29x |
Returns and Efficiency
Return on invested capital is 8.37% over the last 12 months, against a 5-year average of 6.55%.
| Return on Equity (ROE) | 10.43% |
|---|---|
| Return on Assets (ROA) | 6.18% |
| Return on Invested Capital (ROIC) | 8.37% |
| Return on Capital Employed (ROCE) | 9.52% |
| ROE (5Y Average) | 9.21% |
| ROA (5Y Average) | 4.84% |
| ROIC (5Y Average) | 6.55% |
| Asset Turnover | 0.52x |
| Inventory Turnover | 5.27x |
| Receivables Turnover | 4.72x |
| Cash Conversion Cycle | 77 days |
Taxes
Income tax took 20.13% of pretax income over the last 12 months.
| Income Tax (TTM) | $270.00M |
|---|---|
| Effective Tax Rate | 20.13% |
Scores
XYL has an Altman Z-Score of 3.14, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.14 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $9.06B over the last 12 months is up 1.86% from the 12 months before.
| Revenue | $9.06B |
|---|---|
| Revenue Growth (YoY) | +1.86% |
| Gross Profit | $3.60B |
| Operating Income | $1.37B |
| Pretax Income | $1.34B |
| Net Income | $1.07B |
| EBITDA | $1.94B |
| EBIT | $1.38B |
| Reported EPS (TTM) | $5.44 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 59.26% of the $17.33B in total assets.
| Cash and Equivalents | $708.00M |
|---|---|
| Total Debt | $2.90B |
| Net Debt | $2.19B |
| Net Debt Per Share | $9.40 |
| Working Capital | $1.11B |
| Shareholder Equity | $10.27B |
| Book Value Per Share | $44.13 |
| Tangible Book Value | -$475.00M |
| Total Assets | $17.33B |
| Total Liabilities | $6.82B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $351.00M of capital spending, operating cash flow left $921.00M of free cash flow.
| Operating Cash Flow | $1.27B |
|---|---|
| Capital Expenditures | $351.00M |
| Free Cash Flow | $921.00M |
| FCF Per Share | $3.94 |
| Depreciation and Amortization | $560.00M |
| Dividends Paid | $405.00M |
| Share Repurchases | $1.58B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 15.15%, against a 5-year average of 11.34%.
| Gross Margin | 39.79% |
|---|---|
| Operating Margin | 15.15% |
| Pretax Margin | 14.80% |
| Net Margin | 11.82% |
| EBITDA Margin | 21.40% |
| EBIT Margin | 15.22% |
| FCF Margin | 10.17% |
| Gross Margin (5Y Average) | 37.73% |
| Operating Margin (5Y Average) | 11.34% |
| Net Margin (5Y Average) | 8.77% |
Growth
Revenue grew 17.84% a year over 3 years, and EPS 21.39% a year.
| Revenue Growth (3Y CAGR) | +17.84% |
|---|---|
| Revenue Growth (5Y CAGR) | +13.13% |
| EPS Growth (3Y CAGR) | +21.39% |
| EPS Growth (5Y CAGR) | +19.78% |
| FCF Growth (3Y CAGR) | +32.86% |
| FCF Growth (5Y CAGR) | +7.26% |
| Operating Income Growth (3Y CAGR) | +25.28% |
| Book Value Per Share Growth (2Y CAGR) | +5.72% |
| Tangible Book Per Share Growth (2Y CAGR) | +316.42% |
Dividends and Yields
XYL pays out 30.92% of earnings as dividends.
| Dividend Per Share (Annual) | $1.72 |
|---|---|
| Dividend Yield | 1.82% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +10.06% |
| Dividend Growth (5Y CAGR) | +9.00% |
| Payout Ratio | 30.92% |
| FCF Payout Ratio | 43.97% |
| Earnings Yield | 5.75% |
| FCF Yield | 4.18% |
| Buyback Yield | 7.18% |
| Shareholder Yield | 9.02% |
Peer Position
Against 12 similar companies, XYL has the 11th highest P/E and the 9th highest P/S.
P/E RatioPeer median 24.1x
P/S RatioPeer median 3.7x
ROICPeer median 12.42%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.39%
Dividend YieldPeer median 1.14%
| P/E Ratio | 17.4x vs 24.1x median |
|---|---|
| P/S Ratio | 2.4x vs 3.7x median |
| ROIC | 8.37% vs 12.42% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +1.86% vs +7.39% median |
| Dividend Yield | 1.82% vs 1.14% median |
Analyst Forecast
Consensus estimates put revenue growth at 1.33% and EPS growth at 7.32% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +1.33% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +7.32% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About XYL
What is XYL's market cap?
Xylem has a market cap of $21.60B. Its enterprise value, which adds debt and subtracts cash, is $23.79B.
What is XYL's P/E ratio?
Xylem has a trailing P/E ratio of 17.4x and a forward P/E of 17.3x.
How many shares of XYL are outstanding?
Xylem has 232.72M shares outstanding. The count is down 4.41% from a year earlier.
Does XYL pay a dividend?
Yes. Xylem pays $1.72 a share a year, a dividend yield of 1.82%.
How much debt does XYL have?
Xylem has $2.90B of total debt and $708.00M of cash and equivalents, a net debt position of $2.19B.
XYL pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts